Share
 
Title
What has COVID-19 changed in vaccine R&D and what remains to change for an HIV vaccine?
Code
SA098
Session Type
Satellite
Format
Hybrid
ROOM/CHANNEL
Room 524/Channel 9
Date Time
01 August 17:45 - 19:15
Chair
Julie AKE, U.S. Military HIV Research Program, United States
Organizer
IAS - the International AIDS Society/Global HIV Vaccine Enterprise

The rapidity of COVID-19 vaccine development and distribution has shown us that the urgency to end an epidemic can be successful and that funding for research can be found within months. The development of the vaccine has proved that public institutions, universities, pharmaceutical companies and non-profit organisations can work together to create life-long technologies. Through a panel discussion we will look what are the lessons learnt to be applied on the efforts to develop an HIV vaccine.

17:45
3 min
 Introduction
Julie AKE, U.S. Military HIV Research Program, United States
17:48
15 min
 1. Better products, new platforms, new strategies: what COVID-19 has changed in HIV vaccine sciences
Dan BAROUCH, Center for Virology and Vaccine Research, BIDMC, United States
18:03
8 min
 2. What has COVID-19 changed in clinical trial management
Fatima LAHER, Director of the PHRU Vaccines Research Centre, South Africa
18:11
18 min
 3. Community engagement in clinical research: Better prepared, better engaged?
Stacey HANNAH, AVAC, United States
18:29
15 min
 5. Regulatory approval: Are we better prepared for a successful HIV vaccine?
Eric KARIKARI - BOATENG, Centre for Laboratory Services and Research, FDA Ghana, Ghana
18:44
28 min
 Panel discussion-Promise held or still much more to do.
Mitchell WARREN, AVAC, United States
Dan BAROUCH, Center for Virology and Vaccine Research, BIDMC, United States
Julie AKE, U.S. Military HIV Research Program, United States
Fatima LAHER, Director of the PHRU Vaccines Research Centre, South Africa
Eric KARIKARI - BOATENG, Centre for Laboratory Services and Research, FDA Ghana, Ghana
19:12
3 min
 Closing remarks
Julie AKE, U.S. Military HIV Research Program, United States